Episode #3: Implementing GA Treatments IME Expert Series: Modern Diagnosis and Treatment Approaches for Dry AMD and Geographic Atrophy   In this episode of the EURETINA IME podcast series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore emerging complement pathway-targeting treatments for GA. They discuss key aspects, including patient selection, integrating these treatments into the GA patient workflow, and effectively communicating potential side effects. Prof. Holz and Dr. Khanani also address rare adverse events and provide recommendations on how to avoid or manage them. Finally, they share valuable real-world insights on the use of these therapies. Make sure to listen the other two podcasts in this series! Independent medical education supported by Apellis and Astellas Pharma.  

AMD Episode #2: Diagnosing and Monitoring dry AMD IME Expert Series: Modern Diagnosis and Treatment Approaches for Dry AMD and Geographic Atrophy In this episode of the EURETINA IME podcast series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani discuss essential diagnostic modalities for dry AMD, highlighting what to look for to enable an early diagnosis. They explore how to classify the disease stage using established grading systems, identify predictors of rapid disease progression, and discuss strategies for managing them. Additionally, they provide guidance on when general ophthalmologists should refer dry AMD and geographic atrophy patients to a retina specialist for further care. Make sure to listen the other two podcasts in this series! Independent medical education supported by Apellis and Astellas Pharma.

AMD Episode #1: Understanding the Impact of Dry AMD and GA  IME Expert Series: Modern Diagnosis and Treatment Approaches for Dry AMD and Geographic Atrophy In this episode of the EURETINA IME podcast series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani discuss the prevalence of dry AMD and GA, highlight major risk factors, and stress the profound impact of GA on patients’ quality of life. They emphasise the critical importance of early intervention to preserve vision and independence, outlining key functional and anatomical changes that can help detect progression early, allowing for timely intervention. Make sure to listen the other two podcasts in this series! Independent medical education supported by Apellis and Astellas Pharma.

IRD Episode #4: Future Directions IME Expert Series: Fundamentals of the Diagnosis and Management of IRD In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus discuss promising treatment strategies, including gene-specific targeted therapies and broader, agnostic approaches that may address multiple genes or underlying pathogenic mechanisms. They also provide an overview of ongoing cell therapy clinical trials and highlight gaps in current clinical care pathways. Be sure to listen to the other podcasts in this series! Independent medical education supported by Johnson & Johnson, Neurotech Pharmaceuticals and Alkeus Pharmaceuticals.

IRD Episode #3: Managing IRD patients IME Expert Series: Fundamentals of the Diagnosis and Management of IRD In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus underscore the importance of early detection, regular follow-ups, and referrals to specialized centers, enabling IRD patients to receive comprehensive assessments, including functional and genetic testing. They also discuss the effectiveness of current treatments, common barriers to access, and the critical need to boost awareness and education among patients and healthcare providers. Be sure to listen to the other podcasts in this series! Independent medical education supported by Johnson & Johnson, Neurotech Pharmaceuticals and Alkeus Pharmaceuticals.

Episode #2: Patient Communication IME Expert Series: Fundamentals of the Diagnosis and Management of IRD Retinal Diseases  In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black discuss key strategies for effectively communicating IRD diagnoses to patients. They address common misconceptions, clarify essential terminology, and emphasise the vital role of genetic counsellors in guiding patients towards understanding their diagnosis and making informed choices. Drs. Pfau and Black also highlight the importance of involving family members, connecting with support groups, and utilising available resources. Be sure to listen to the other podcasts in this series! Independent medical education supported by Johnson & Johnson, Neurotech Pharmaceuticals and Alkeus Pharmaceuticals.

Episode #1: Diagnosing IRDs IME Expert Series: Fundamentals of the Diagnosis and Management of IRD   In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black explore the complexities of diagnosing IRDs, emphasizing the importance of a multidisciplinary approach. They discuss key diagnostic elements, challenges, and the potential of artificial intelligence to enhance diagnostic efficiency. Be sure to listen to the other podcasts in this series! Independent medical education supported by Johnson & Johnson, Neurotech Pharmaceuticals and Alkeus Pharmaceuticals.